Subject: thymic carcinoma | targeted therapy | thymus | thymoma; thymic carcinoma; thymus; apoptosis; gene expression; myasthenia gravis; MTCH2; targeted therapy | myasthenia gravis | apoptosis | Oncology | Neoplasms. Tumors. Oncology. Including cancer and carcinogens | MTCH2 | RC254-282 | Original Research | thymoma | gene expression
The molecular pathogenesis of thymomas and thymic carcinomas (TCs) is poorly understood and results of adjuvant therapy are unsatisfactory in case of metastatic disease and tumor recurrence. For these clinical settings, novel therapeutic strategies are urgently needed. ... View more
1 Rosai J. Histological Typing of Tumours of the Thymus. 2nd ed. Berlin: Springer-Verlag (1999).
2 Müller-Hermelink HK Möller P Engel P Menestrina F Kuo TT Shimosato Y Tumours of the thymus. In: Travis WD Brambilla E Müller-Hermelink HK Harris CC, editors. Tumours of the Lung, Thymus, and Heart Pathology and Genetics. Lyon: IARC Press (2004). p. 145–51.